Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity. | Canada Hyperbarics Skip to main content
Review Basic and clinical andrology 2022

Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Paladini A, Cochetti G, Tancredi A, Mearini M, Vitale A, Pastore F, et al. — Basic and clinical andrology, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a narrative literature review on Fournier's gangrene management during the COVID-19 pandemic, supplemented by a detailed case report.

What They Found

They presented a case of a 60-year-old man with Fournier's gangrene and a severity index of 9, who received prompt broad-spectrum antibiotic therapy and surgical debridement. The patient, also suffering from diabetes and ulcerative colitis, underwent daily bedside wound care, demonstrating a multimodal approach to managing this severe condition during the pandemic.

What This Means for Canadian Patients

Early diagnosis and aggressive, multidisciplinary treatment are crucial for Canadian patients with Fournier's gangrene, especially given its high mortality risk. This case study reinforces the importance of comprehensive care, including antibiotics, surgery, and intensive support, even in challenging healthcare environments like a pandemic.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a narrative review supplemented by a single case report, the findings may not be generalizable to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category COVID-19 / Long COVID
Source Pubmed
PubMed ID 35850577
Year Published 2022
Journal Basic and clinical andrology

Cite This Study

Share

This study relates to Long COVID. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology